-+ 0.00%
-+ 0.00%
-+ 0.00%

*Artelo Biosciences: New Nonclinical Findings Showed About 20% Weight Loss With ART27.13 Monotherapy, Comparable to Semaglutide >ARTL

Dow Jones·11/12/2026 13:03:00

Please log in to view news